Search results
How Hypertrophic Cardiomyopathy Progresses in Adults
Time via Yahoo News· 3 months agoTreatment sometimes involves an implantable defibrillator. Credit - Karsten Eggert—Getty Images Hypertrophic cardiomyopathy is the most common form of...
Dr. Hersh: Hypertrophic cardiomyopathy occurs when heart muscle becomes too thick
The Metrowest Daily News via Yahoo News· 3 months agoHypertrophic cardiomyopathy (HCM) is a condition where some of the heart muscle becomes too thick,...
Cytokinetics (CYTK) Up 83% as Cardiomyopathy Drug Meets Goals
Zacks via Yahoo Finance· 6 months agoCytokinetics (CYTK) reports positive results from its pivotal late-stage study of aficamten in...
Edgewise Therapeutics doses first subject in HCM drug trial
Clinical Trials Arena via Yahoo Finance· 2 months agoUS-based biopharmaceutical company Edgewise Therapeutics has dosed the first subject in the Phase II...
Cytokinetics (CYTK) Rises on Reports of Buyout by Novartis
Zacks via Yahoo Finance· 5 months agoShares of Cytokinetics, Incorporated CYTK increased 15.29% after reports of a plausible acquisition...
Cytokinetics Posts Aficamten Data In Patients With Thickened Heart Muscle
Benzinga via Yahoo Finance· 1 year agoCytokinetics Incorporated (NASDAQ: CYTK) presented results from Cohort 4 of REDWOOD-HCM Phase 2...
Bristol Myers (BMY) Gets FDA Nod for Data Addition to Camzyos
Zacks via Yahoo Finance· 1 year agoBristol Myers Squibb BMY announced that the FDA approved the supplemental new drug application...
Bristol Myers (BMY) Up 14.6% YTD: Will the Performance Continue?
Zacks via Yahoo Finance· 2 years agoShares of Bristol Myers BMY have gained 14.6% in the year so far against the industry’s decline of...
Will Bristol Myers (BMY) Gain From New Drugs' Label Expansion?
Zacks via Yahoo Finance· 1 year agoBristol-Myers Squibb BMY has recently been enjoying a string of positive regulatory updates. The...
Novartis in advanced talks to buy Cytokinetics- source
Reuters via Yahoo News· 5 months agoNovartis is poised to prevail in the auction for Cytokinetics, ahead of other bidders that include...